Clinical Significance of CEA and CA19-9 in Postoperative Follow-up of Colorectal Cancer

被引:82
作者
Yakabe, Tomomi [2 ]
Nakafusa, Yuji [1 ]
Sumi, Kenji [2 ]
Miyoshi, Atsushi [2 ]
Kitajima, Yoshihiko [2 ]
Sato, Seiji [3 ]
Noshiro, Hirokazu [2 ]
Miyazaki, Kohji [2 ]
机构
[1] Fukuoka Red Cross Hosp, Dept Surg, Fukuoka, Japan
[2] Saga Univ, Fac Med, Dept Surg, Saga 840, Japan
[3] Saga Prefectural Hosp KOSEIKAN, Dept Surg, Saga, Japan
关键词
OPERATING CHARACTERISTIC CURVES; TUMOR-MARKERS; LIKELIHOOD RATIOS; CARCINOEMBRYONIC ANTIGEN; CURATIVE RESECTION; PRACTICE GUIDELINE; CONTROLLED-TRIAL; DIAGNOSTIC-TEST; ROC CURVE; CARCINOMA;
D O I
10.1245/s10434-010-1004-5
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Background. We evaluated the efficiency of CEA and CA19-9 as tools for diagnosing recurrence in the postoperative surveillance of colorectal cancer. Materials and Methods. A total of 227 patients who underwent curative resection for colorectal cancer between 1999 and 2003 at our hospital received complete follow-up according to the schedule determined prospectively. Using receiver operating characteristic (ROC) analysis, performance of postoperative values of CEA or CA19-9 for detecting recurrence was assessed. Results. The sensitivity (1.000) and specificity (0.978) of the postoperative values of CEA in the high preoperative CEA group were very high. Even in the normal preoperative CEA group, the area under the curve (AUC) of the ROC curve of CEA (0.740, 95% confidence interval [95% CI], 0.628-0.852) was significantly larger than 0.5 (P < 0.001). The postoperative values of CA19-9 showed high sensitivity (0.833) and specificity (0.900) in the high preoperative CA19-9 group, while the AUC of the ROC curve of the normal preoperative group was as small as 0.510 (95% Cl, 0.376-0.644). In the high preoperative CA19-9 group, however, there was no significant difference between the AUC of CA 19-9 (0.904, 95% Cl, 0.786-1.000) and that of CEA (0.869, 95% Cl, 0.744-0.994) (P = 0.334). Conclusions. The measurement of CEA is an efficient way to detect recurrence. The efficiency of measuring CA19-9 for the purpose of detecting recurrence is low, especially in patients with a normal level of preoperative CA19-9. Even in patients with a high preoperative level of CA19-9, CEA might be able to fill the role of CA19-9.
引用
收藏
页码:2349 / 2356
页数:8
相关论文
共 38 条
  • [1] The central role of receiver operating characteristic (ROC) curves in evaluating tests for the early detection of cancer
    Baker, SG
    [J]. JOURNAL OF THE NATIONAL CANCER INSTITUTE, 2003, 95 (07) : 511 - 515
  • [2] ROLE OF CEA, TPA, AND CA 19-9 IN THE EARLY DETECTION OF LOCALIZED AND DIFFUSE RECURRENT RECTAL-CANCER
    BARILLARI, P
    BOLOGNESE, A
    CHIRLETTI, P
    CARDI, M
    SAMMARTINO, P
    STIPA, V
    [J]. DISEASES OF THE COLON & RECTUM, 1992, 35 (05) : 471 - 476
  • [3] Detection of prostate cancer by integration of line-scan diffusion, T2-mapping and T2-weighted magnetic resonance imaging; a multichannel statistical classifier
    Chan, I
    Wells, W
    Mulkern, RV
    Haker, S
    Zhang, JQ
    Zou, KH
    Maier, SE
    Tempany, CMC
    [J]. MEDICAL PHYSICS, 2003, 30 (09) : 2390 - 2398
  • [4] Is it reasonable to add preoperative serum level of CEA and CA19-9 to staging for colorectal cancer?
    Chen, CC
    Yang, SH
    Lin, JK
    Lin, TC
    Chen, WS
    Jiang, JK
    Wang, HS
    Chang, SC
    [J]. JOURNAL OF SURGICAL RESEARCH, 2005, 124 (02) : 169 - 174
  • [5] Choi BCK, 1998, AM J EPIDEMIOL, V148, P1127
  • [6] Colorectal cancer surveillance: 2005 update of an American Society of Clinical Oncology practice guideline
    Desch, CE
    Benson, A
    Somerfield, MR
    Flynn, PJ
    Krause, C
    Loprinzi, CL
    Minsky, BD
    Pfister, DG
    Virgo, KS
    Petrelli, NJ
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2005, 23 (33) : 8512 - 8519
  • [7] Clinical utility of biochemical markers in colorectal cancer: European Group on Tumour Markers (EGTM) guidelines
    Duffy, MJ
    van Dalen, A
    Haglund, C
    Hansson, L
    Klapdor, R
    Lamerz, R
    Nilsson, O
    Sturgeon, C
    Topolcan, O
    [J]. EUROPEAN JOURNAL OF CANCER, 2003, 39 (06) : 718 - 727
  • [8] Eche N, 2001, B CANCER, V88, P1177
  • [9] Follow-up of patients with curatively resected colorectal cancer: a practice guideline
    Figueredo, A
    Rumble, RB
    Maroun, J
    Earle, CC
    Cummings, B
    McLeod, R
    Zuraw, L
    Zwaal, C
    [J]. BMC CANCER, 2003, 3 (1)
  • [10] A readers' guide to the interpretation of diagnostic test properties: clinical example of sepsis
    Fischer, JE
    Bachmann, LM
    Jaeschke, R
    [J]. INTENSIVE CARE MEDICINE, 2003, 29 (07) : 1043 - 1051